These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8655354

  • 1. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.
    Zucker C, Zucker K, Asthana D, Carreno M, Viciana AL, Ruiz P, Esquenazi V, Nery J, Burke G, Miller J.
    Hum Immunol; 1996 Jan; 45(1):1-12. PubMed ID: 8655354
    [Abstract] [Full Text] [Related]

  • 2. Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reaction.
    Koutouby R, Zucker C, Zucker K, Burke G, Nery J, Roth D, Esquenazi V, Miller J.
    Hum Immunol; 1993 Apr; 36(4):227-34. PubMed ID: 8340231
    [Abstract] [Full Text] [Related]

  • 3. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
    Rostaing L, Puyoo O, Tkaczuk J, Peres C, Rouzaud A, Cisterne JM, de Preval C, Ohayon E, Durand D, Abbal M.
    Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
    [Abstract] [Full Text] [Related]

  • 4. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group.
    Transplantation; 2001 Sep 27; 72(6):1024-32. PubMed ID: 11579295
    [Abstract] [Full Text] [Related]

  • 5. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 27; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells.
    Kobayashi T, Momoi Y, Iwasaki T.
    J Vet Med Sci; 2007 Sep 27; 69(9):887-92. PubMed ID: 17917372
    [Abstract] [Full Text] [Related]

  • 7. Molecular and structural consequences of early renal allograft injury.
    Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.
    Kidney Int; 2002 Feb 27; 61(2):686-96. PubMed ID: 11849412
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
    Härtel C, Schumacher N, Fricke L, Ebel B, Kirchner H, Müller-Steinhardt M.
    Clin Chem; 2004 Jan 27; 50(1):141-51. PubMed ID: 14709642
    [Abstract] [Full Text] [Related]

  • 9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 10. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
    Koziolek MJ, Riess R, Geiger H, Thévenod F, Hauser IA.
    Kidney Int; 2001 Jul 27; 60(1):156-66. PubMed ID: 11422747
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine.
    Iacono A, Dauber J, Keenan R, Spichty K, Cai J, Grgurich W, Burckart G, Smaldone G, Pham S, Ohori NP, Yousem S, Williams P, Griffith B, Zeevi A.
    Transplantation; 1997 Jul 27; 64(2):263-9. PubMed ID: 9256185
    [Abstract] [Full Text] [Related]

  • 12. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Clin Exp Nephrol; 2007 Jun 27; 11(2):151-155. PubMed ID: 17593515
    [Abstract] [Full Text] [Related]

  • 13. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR.
    Am J Kidney Dis; 1999 Jul 27; 34(1):69-84. PubMed ID: 10401019
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N, Kahan BD.
    Transplantation; 1985 Dec 27; 40(6):661-6. PubMed ID: 3934806
    [Abstract] [Full Text] [Related]

  • 15. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 16. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC, Fisher RA, Dattilo JB, Cohen DS, Tawes JW, Dattilo MP, Babcock GF, Frede SE, Wakely PE, Posner MP.
    Transplantation; 1997 Jan 27; 63(2):310-4. PubMed ID: 9020336
    [Abstract] [Full Text] [Related]

  • 17. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
    Seyhun Y, Ciftci HS, Kekik C, Karadeniz MS, Tefik T, Nane I, Turkmen A, Oguz FS, Aydin F.
    Int J Immunogenet; 2015 Jun 27; 42(3):147-60. PubMed ID: 25817300
    [Abstract] [Full Text] [Related]

  • 18. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J, Slowinski T, Brinker-Paschke A, Budde K, Schreiber M, Böhler T, Hauser I, Neumayer HH.
    Nephrol Dial Transplant; 2002 Jul 27; 17(7):1310-7. PubMed ID: 12105257
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
    Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K.
    Transplantation; 2008 Jan 27; 85(2):179-84. PubMed ID: 18212621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.